KR970705386A - 치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone) - Google Patents
치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone)Info
- Publication number
- KR970705386A KR970705386A KR1019970701096A KR19970701096A KR970705386A KR 970705386 A KR970705386 A KR 970705386A KR 1019970701096 A KR1019970701096 A KR 1019970701096A KR 19970701096 A KR19970701096 A KR 19970701096A KR 970705386 A KR970705386 A KR 970705386A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- oralbone
- methods
- maintaining teeth
- rti
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29423794A | 1994-08-22 | 1994-08-22 | |
US08/294,237 | 1994-08-22 | ||
PCT/US1995/010582 WO1996005829A1 (fr) | 1994-08-22 | 1995-08-21 | Procede pour conserver en etat les dents et les os alveolaire et maxilaires |
Publications (1)
Publication Number | Publication Date |
---|---|
KR970705386A true KR970705386A (ko) | 1997-10-09 |
Family
ID=23132491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019970701096A KR970705386A (ko) | 1994-08-22 | 1995-08-21 | 치아 및 구강 뼈의 유지방법(methods of maintaining teeth and oralbone) |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0769946A4 (fr) |
JP (1) | JPH10504573A (fr) |
KR (1) | KR970705386A (fr) |
AU (1) | AU692598B2 (fr) |
CA (1) | CA2198108A1 (fr) |
CZ (1) | CZ52197A3 (fr) |
FI (1) | FI970713A (fr) |
HU (1) | HUT76891A (fr) |
IL (1) | IL115017A0 (fr) |
MX (1) | MX9701331A (fr) |
NO (1) | NO970784D0 (fr) |
WO (1) | WO1996005829A1 (fr) |
YU (1) | YU55495A (fr) |
ZA (1) | ZA956987B (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6465445B1 (en) | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
TW366342B (en) * | 1992-07-28 | 1999-08-11 | Lilly Co Eli | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss |
-
1995
- 1995-08-21 ZA ZA9506987A patent/ZA956987B/xx unknown
- 1995-08-21 CZ CZ97521A patent/CZ52197A3/cs unknown
- 1995-08-21 KR KR1019970701096A patent/KR970705386A/ko not_active Application Discontinuation
- 1995-08-21 EP EP95930864A patent/EP0769946A4/fr not_active Ceased
- 1995-08-21 IL IL11501795A patent/IL115017A0/xx unknown
- 1995-08-21 MX MX9701331A patent/MX9701331A/es unknown
- 1995-08-21 AU AU34088/95A patent/AU692598B2/en not_active Ceased
- 1995-08-21 JP JP8508232A patent/JPH10504573A/ja active Pending
- 1995-08-21 CA CA002198108A patent/CA2198108A1/fr not_active Abandoned
- 1995-08-21 HU HU9701352A patent/HUT76891A/hu unknown
- 1995-08-21 YU YU55495A patent/YU55495A/sh unknown
- 1995-08-21 WO PCT/US1995/010582 patent/WO1996005829A1/fr not_active Application Discontinuation
-
1997
- 1997-02-20 NO NO970784A patent/NO970784D0/no unknown
- 1997-02-20 FI FI970713A patent/FI970713A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
MX9701331A (es) | 1997-05-31 |
CA2198108A1 (fr) | 1996-02-29 |
ZA956987B (en) | 1997-02-21 |
AU692598B2 (en) | 1998-06-11 |
EP0769946A4 (fr) | 1997-11-05 |
WO1996005829A1 (fr) | 1996-02-29 |
HUT76891A (en) | 1997-12-29 |
YU55495A (sh) | 1998-07-10 |
NO970784L (no) | 1997-02-20 |
AU3408895A (en) | 1996-03-14 |
NO970784D0 (no) | 1997-02-20 |
EP0769946A1 (fr) | 1997-05-02 |
FI970713A0 (fi) | 1997-02-20 |
CZ52197A3 (en) | 1997-08-13 |
FI970713A (fi) | 1997-02-20 |
JPH10504573A (ja) | 1998-05-06 |
IL115017A0 (en) | 1995-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR950016725A (ko) | 폐 고혈압성 질병을 억제하는 방법 | |
KR970706818A (ko) | 뉴로펩티드 y와 관련된 상태의 억제 방법(methods of inhibiting conditions associated with neuropeptide) | |
KR950010893A (ko) | 자궁내막증 억제 방법 | |
KR950016732A (ko) | 피부 및 질의 위축 억제방법 | |
KR950016738A (ko) | 알쯔하이머 질병의 억제 방법 | |
KR950016746A (ko) | 비-펩티드 타키키닌 수용체 길항물질 | |
KR950010892A (ko) | 자궁 섬유증 억제 방법 | |
KR950016744A (ko) | 트롬빈을 저해하는 방법 | |
KR950016723A (ko) | 자가면역 질병의 억제 방법 | |
KR950016745A (ko) | 생리증상의 치료방법 및 이를 위한 조성물 | |
KR950016731A (ko) | 지루 및 좌창의 억제 방법 | |
KR950016724A (ko) | 폐경기 후 여성의 리비도를 증가시키는 방법 | |
KR950016726A (ko) | 기능부전성 자궁 출혈을 억제하는 방법 | |
KR950010889A (ko) | 혈관형성 및 혈관형성성 질병을 억제하는 방법 | |
MX9701325A (es) | Metodos para inhibir la mucositis ulcerativa. | |
KR950016727A (ko) | 트롬보모듈린 발현을 증가시키는 방법 | |
KR950016730A (ko) | 폐경기 후 증후군과 관련한 혈관 운동 증상 및 수반되는 심리학적 장애의 억제 방법 | |
KR950010891A (ko) | 내성 종양을 치료하는 방법 | |
KR950010887A (ko) | 연골 퇴화 억제 방법 | |
KR950016742A (ko) | 폐경후 여성의 씨엔에스 질환을 억제하는 방법 | |
KR950016734A (ko) | 성적 조숙증의 억제방법 | |
KR970705384A (ko) | 골 보철 파손의 억제 방법(methods for inhibiting bone prosthesis degeneration) | |
KR950016729A (ko) | 유방 질환의 억제 방법 | |
KR950016735A (ko) | 터너 증후군의 억제 방법 | |
KR950016741A (ko) | 체중 증가를 억제하거나 또는 체중 감소를 유도하는 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |